Hasane Ratni

2.4k total citations
21 papers, 606 citations indexed

About

Hasane Ratni is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Hasane Ratni has authored 21 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Genetics and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Hasane Ratni's work include Neurogenetic and Muscular Disorders Research (10 papers), RNA modifications and cancer (7 papers) and RNA Research and Splicing (7 papers). Hasane Ratni is often cited by papers focused on Neurogenetic and Muscular Disorders Research (10 papers), RNA modifications and cancer (7 papers) and RNA Research and Splicing (7 papers). Hasane Ratni collaborates with scholars based in Switzerland, United States and Russia. Hasane Ratni's co-authors include R. Scalco, Alexander Stephan, Nikolai A. Naryshkin, Sergey Paushkin, Marla Weetall, Caterina Bissantz, Katja Heinig, Agnès Poirier, Lutz Mueller and Antoine Cléry and has published in prestigious journals such as Blood, Neurology and Journal of Medicinal Chemistry.

In The Last Decade

Hasane Ratni

20 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hasane Ratni Switzerland 12 445 278 102 64 55 21 606
Nancy Thomas Canada 13 165 0.4× 14 0.1× 89 0.9× 31 0.5× 80 1.5× 26 380
Shuichi Shimakawa Japan 13 220 0.5× 51 0.2× 34 0.3× 44 0.7× 73 1.3× 44 559
Željko Uzelac Germany 13 337 0.8× 217 0.8× 127 1.2× 6 0.1× 271 4.9× 28 709
B. Lammek Poland 12 257 0.6× 72 0.3× 10 0.1× 61 1.0× 89 1.6× 43 441
Sandy Wilson United States 9 167 0.4× 13 0.0× 36 0.4× 31 0.5× 79 1.4× 19 389
A. Carruette France 12 485 1.1× 28 0.1× 29 0.3× 24 0.4× 582 10.6× 21 690
Sara Guzzetti Italy 11 115 0.3× 39 0.1× 11 0.1× 9 0.1× 109 2.0× 17 325
José Bernardo Noronha‐Matos Portugal 12 142 0.3× 34 0.1× 37 0.4× 10 0.2× 63 1.1× 20 356
Vincenzo Proietto France 9 731 1.6× 34 0.1× 38 0.4× 23 0.4× 934 17.0× 9 1.1k
Minako Abe Japan 7 187 0.4× 15 0.1× 7 0.1× 30 0.5× 74 1.3× 14 378

Countries citing papers authored by Hasane Ratni

Since Specialization
Citations

This map shows the geographic impact of Hasane Ratni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hasane Ratni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hasane Ratni more than expected).

Fields of papers citing papers by Hasane Ratni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hasane Ratni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hasane Ratni. The network helps show where Hasane Ratni may publish in the future.

Co-authorship network of co-authors of Hasane Ratni

This figure shows the co-authorship network connecting the top 25 collaborators of Hasane Ratni. A scholar is included among the top collaborators of Hasane Ratni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hasane Ratni. Hasane Ratni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rauch, Sebastian, Stefan O. Reber, Montserrat Pérez-Salvia, et al.. (2024). Sky-1214, a Small Molecule Splicing Modulator Targeting FANCL and Fanci, Provides a New Mechanism of Action Targeting Multiple Myeloma and Non-Hodgkin's Lymphoma. Blood. 144(Supplement 1). 2784–2784. 1 indexed citations
2.
Rauch, Sebastian, Massimo Pregnolato, Leanne Berry, et al.. (2024). 116 (PB104): Preclinical characterization of SKY-1214, a small molecule splicing modulator of Fanconi Anemia pathway members for the treatment of multiple myeloma and non-Hodgkin’s lymphoma. European Journal of Cancer. 211. 114639–114639. 1 indexed citations
3.
Zhao, Xin, Zhihua Feng, Nicole Risher, et al.. (2021). SMN protein is required throughout life to prevent spinal muscular atrophy disease progression. Human Molecular Genetics. 31(1). 82–96. 6 indexed citations
4.
Ratni, Hasane, Karlheinz Baumann, Peter Bellotti, et al.. (2021). Phenyl bioisosteres in medicinal chemistry: discovery of novel γ-secretase modulators as a potential treatment for Alzheimer's disease. RSC Medicinal Chemistry. 12(5). 758–766. 15 indexed citations
5.
Ratni, Hasane, R. Scalco, & Alexander Stephan. (2021). Risdiplam, the First Approved Small Molecule Splicing Modifier Drug as a Blueprint for Future Transformative Medicines. ACS Medicinal Chemistry Letters. 12(6). 874–877. 68 indexed citations
6.
Schnider, Patrick, Caterina Bissantz, Andreas Bruns, et al.. (2020). Discovery of Balovaptan, a Vasopressin 1a Receptor Antagonist for the Treatment of Autism Spectrum Disorder. Journal of Medicinal Chemistry. 63(4). 1511–1525. 39 indexed citations
7.
Ratni, Hasane, André Alker, Caterina Bissantz, et al.. (2020). Discovery of RO7185876, a Highly Potent γ-Secretase Modulator (GSM) as a Potential Treatment for Alzheimer’s Disease. ACS Medicinal Chemistry Letters. 11(6). 1257–1268. 17 indexed citations
8.
Campagne, Sébastien, Simon Rüdisser, Ahmed Moursy, et al.. (2019). Structural basis of a small molecule targeting RNA for a specific splicing correction. Nature Chemical Biology. 15(12). 1191–1198. 96 indexed citations
9.
Ratni, Hasane, Lutz Mueller, & Martin Ebeling. (2019). Rewriting the (tran)script: Application to spinal muscular atrophy. Progress in medicinal chemistry. 58. 119–156. 6 indexed citations
10.
Poirier, Agnès, Marla Weetall, Katja Heinig, et al.. (2018). Risdiplam distributes and increases SMN protein in both the central nervous system and peripheral organs. Pharmacology Research & Perspectives. 6(6). e00447–e00447. 114 indexed citations
11.
Guenther, Andreas, Birgit Jaber, Paul Jordan, et al.. (2018). A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier. British Journal of Clinical Pharmacology. 85(1). 181–193. 74 indexed citations
12.
Poirier, Agnès, Marla Weetall, Hasane Ratni, et al.. (2018). Relationship Between Central and Peripheral SMN Protein Increase Upon Treatment with RO7034067 (RG7916) (S46.007). Neurology. 90(15_supplement). 1 indexed citations
13.
Pinard, Emmanuel, Luke Green, Michael Reutlinger, et al.. (2017). Discovery of a Novel Class of Survival Motor Neuron 2 Splicing Modifiers for the Treatment of Spinal Muscular Atrophy. Journal of Medicinal Chemistry. 60(10). 4444–4457. 23 indexed citations
14.
Marquet, Anne, Heidemarie Kletzl, Andreas Günther, et al.. (2017). Oral SMN2 splicing modifiers in spinal muscular atrophy: Proof-of-mechanism and ongoing clinical studies. European Journal of Paediatric Neurology. 21. e226–e226. 1 indexed citations
15.
Feng, Zhihua, Karen Ling, Xin Zhao, et al.. (2016). Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset. Human Molecular Genetics. 25(5). 964–975. 48 indexed citations
16.
Ratni, Hasane, Mark Rogers‐Evans, Caterina Bissantz, et al.. (2015). Discovery of Highly Selective Brain-Penetrant Vasopressin 1a Antagonists for the Potential Treatment of Autism via a Chemogenomic and Scaffold Hopping Approach. Journal of Medicinal Chemistry. 58(5). 2275–2289. 40 indexed citations
17.
Malherbe, Pari, Frédéric Knoflach, Anne Marcuz, et al.. (2014). Mapping the binding pocket of a novel, high-affinity, slow dissociating tachykinin NK3 receptor antagonist: Biochemical and electrophysiological characterization. Neuropharmacology. 86. 259–272. 4 indexed citations
18.
Malherbe, Pari, Caterina Bissantz, Anne Marcuz, et al.. (2008). Me-Talnetant and Osanetant Interact within Overlapping but Not Identical Binding Pockets in the Human Tachykinin Neurokinin 3 Receptor Transmembrane Domains. Molecular Pharmacology. 73(6). 1736–1750. 28 indexed citations
19.
Malherbe, Pari, Caterina Bissantz, Frédéric Knoflach, et al.. (2008). MAPPING THE BINDING SITE FOR TACHYKININ NK3 RECEPTOR ANTAGONISTS. Schizophrenia Research. 102(1-3). 65–65. 1 indexed citations
20.
Kündig, E. Peter, et al.. (2004). Stereoselective chromium- and molybdenum-mediated transformations of arenes. Pure and Applied Chemistry. 76(3). 689–695. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nancy Thomas Breakdown of academic impact, for papers by Shuichi Shimakawa Breakdown of academic impact, for papers by Željko Uzelac Breakdown of academic impact, for papers by B. Lammek Breakdown of academic impact, for papers by Sandy Wilson Breakdown of academic impact, for papers by A. Carruette Breakdown of academic impact, for papers by Sara Guzzetti Breakdown of academic impact, for papers by José Bernardo Noronha‐Matos Breakdown of academic impact, for papers by Vincenzo Proietto Breakdown of academic impact, for papers by Minako Abe
Rankless by CCL
2026